Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/31/2002WO2002086117A1 Compositions and methods to control bleeding
10/31/2002WO2002086113A2 Enzyme and snp marker for disease
10/31/2002WO2002086101A2 Core-glycosylated hcv envelope proteins
10/31/2002WO2002086100A2 Expression of core-glycosylated hcv envelope proteins in yeast
10/31/2002WO2002086093A2 Methods of using a hyaluronan receptor
10/31/2002WO2002086091A2 Method to treat hemophilia by hepatic gene transfer of factor viii/ix with vesicle vector
10/31/2002WO2002086090A2 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002WO2002086089A2 The 76a11 polypeptide and uses thereof
10/31/2002WO2002086087A2 Cytokine protein family
10/31/2002WO2002086079A2 T1r3 a novel taste receptor
10/31/2002WO2002086077A2 Co-expression of zein proteins
10/31/2002WO2002086076A2 Polynucleotides and polypeptides associated with the nf-kb pathway
10/31/2002WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs
10/31/2002WO2002086072A2 Antimicrobial polypeptides and their uses
10/31/2002WO2002086071A2 Cancer-testis antigens
10/31/2002WO2002086070A2 Binding molecules for fc-region polypeptides
10/31/2002WO2002086069A2 Secreted proteins
10/31/2002WO2002086068A2 Methods for producing recombinant coronavirus
10/31/2002WO2002086066A2 Novel expansin polynucleotides, related polypeptides and methods of use
10/31/2002WO2002086063A2 Xenobiotic compound modulated expression systems and uses therefor
10/31/2002WO2002086061A2 Vesicle-associated proteins
10/31/2002WO2002086060A2 Molecular sequence of pig endogenous retrovirus receptors and methods of use
10/31/2002WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence
10/31/2002WO2002085948A1 Repressors for hiv transcription and methods thereof
10/31/2002WO2002085947A1 Soluble protein from malaria parasite
10/31/2002WO2002085943A2 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002WO2002085942A2 A 150 kda tgf-beta 1 accessory receptor acting as a negative modulator of tgf-beta signaling
10/31/2002WO2002085941A2 Modified interferon alpha with reduced immunogenicity
10/31/2002WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002WO2002085939A1 Novel molecules of the card-related protein family and uses thereof
10/31/2002WO2002085938A1 Anti-obesity polypeptides
10/31/2002WO2002085937A2 Inflammation-specific peptides and the uses thereof
10/31/2002WO2002085936A1 Mutants of green fluorescent protein
10/31/2002WO2002085935A1 Cell surface layer-binding protein and utilization thereof
10/31/2002WO2002085934A2 Antibacterial peptides, compositions containing same and uses thereof
10/31/2002WO2002085933A1 Toll-like receptor 5 ligands and methods of use
10/31/2002WO2002085932A2 Constructs and methods for expression of recombinant hcv envelope proteins
10/31/2002WO2002085931A1 Interleukin-1 homolog zil1a7
10/31/2002WO2002085930A2 Immunomodulating agents from parasitic worms and method for isolation thereof
10/31/2002WO2002085927A1 Novel anti-inflammatory peptides
10/31/2002WO2002085923A2 In vivo incorporation of unnatural amino acids
10/31/2002WO2002085922A2 Proteins and nucleic acids encoding same
10/31/2002WO2002085413A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same
10/31/2002WO2002085404A1 Lkb1-binding proteins
10/31/2002WO2002085389A1 A non-lethal method for extracting crude hemocyanin from gastropod molluscs
10/31/2002WO2002085309A2 Composition, formulations & kits for treatment of respiratory & lung disease with anti-sense oligonucleotides & a bronchodilating agent
10/31/2002WO2002085306A2 Use of follistatin to increase muscle mass
10/31/2002WO2002085305A2 Compositions and methods for inducing cancer cell death
10/31/2002WO2002085298A2 Method for detecting breast cancer cells
10/31/2002WO2002085290A2 Edg : modulators of lymphocyte activation and migration
10/31/2002WO2002085286A2 Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals
10/31/2002WO2002085116A1 Sprr1a and axonal regeneration
10/31/2002WO2002085093A2 Replikin peptides and uses thereof
10/31/2002WO2002070565A9 High-affinity antagonists of elr-cxc chemokines
10/31/2002WO2002068585A3 Tip39 polypeptides
10/31/2002WO2002066650A3 Streptococcus pyogenes polypeptides and corresponding dna fragments
10/31/2002WO2002064814A3 Expression of human milk proteins in transgenic plants
10/31/2002WO2002064161A9 Method and compositions for immunization with the pseudomonas v antigen
10/31/2002WO2002061105A9 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
10/31/2002WO2002060949A3 Glycoforms a fas ligand inhibitory protein analog
10/31/2002WO2002060947A3 Glycoforms a fas ligand inhibitory protein analog
10/31/2002WO2002060477A9 Scaffolded fusion polypeptides, compositions for making the same and methods of using the same
10/31/2002WO2002059148A9 A method for identification, isolation and production of antigens to a specific pathogen
10/31/2002WO2002058628A3 Immunotherapeutic methods for extracorporeal modulation of cd36 and its ligands
10/31/2002WO2002055548A8 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
10/31/2002WO2002055547A9 Sfrp and peptide motifs that interact with sfrp and methods of their use
10/31/2002WO2002054066A3 Non-apoptotic forms of cell death and methods of modulation
10/31/2002WO2002052022A3 Selective cytotoxic fusion proteins
10/31/2002WO2002046219A3 Rho-gtpase activating proteins and methods related thereto
10/31/2002WO2002044416A3 Sulfonated diarylrhodamine dyes as fluorescent labels
10/31/2002WO2002042455A3 Modifier of organelle metalbolism
10/31/2002WO2002040544A3 Mutant human factor ix with an increased resistance to inhibition by heparin
10/31/2002WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/31/2002WO2002033080A3 Regulation of human netrin binding membrane receptor unc5h-1
10/31/2002WO2002032959A3 Obesity-specific g protein coupled receptors
10/31/2002WO2002032946A3 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
10/31/2002WO2002029075A3 Multiple inducible gene regulation system
10/31/2002WO2002024912A3 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
10/31/2002WO2002024885A3 Regulation of human g protein-coupled receptor
10/31/2002WO2002018419A3 Nucleotide sequences which code for the ccpa1 gene
10/31/2002WO2002014499A3 Claudin polypeptides
10/31/2002WO2002010392A3 Mammalian dna binding membrane-associated protein-encoding gene and uses
10/31/2002WO2002008434A3 Bicistronic influenza comprising two genes in tandem
10/31/2002WO2002000262A3 Modulation of chromosome function by chromatin remodeling agents
10/31/2002WO2002000250A3 Hiv-1 vaccines and screening methods therefor
10/31/2002WO2001098343A3 Conserved diaphanous-related formin autoregulatory domain (dad)
10/31/2002WO2001093897A3 Angiostatin and endostatin binding proteins and methods of use
10/31/2002WO2001088088A3 Novel nucleic acids and polypeptides
10/31/2002WO2001078790A3 GENE THERAPHY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING A β2ADRENERGIC RECEPTOR GENE
10/31/2002WO2001075067A9 Novel nucleic acids and polypeptides
10/31/2002WO2001068812A9 Methods of stimulating cartilage formation
10/31/2002WO2001061356A9 Her-2 binding antagonists
10/31/2002WO2001059152A3 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
10/31/2002WO2001059065A9 Novel molecules of the card-related protein family and uses thereof
10/31/2002WO2001058953A9 Identification of a domain in the tumor necrosis factor receptor family that mediates pre-ligand receptor assembly and function
10/31/2002WO2001058479A9 Immunotherapy using interleukin 13 receptor subunit alpha 2
10/31/2002WO2001057251A9 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
10/31/2002WO2001057072A3 Pharmacologically active antiviral peptides and methods of their use
10/31/2002WO2001055432A3 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications
10/31/2002WO2001055342A9 Synthetic genes for enhanced expression
1 ... 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 ... 2916